Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Layered Peptide Arrays-high Throughput Screening

  • Read more about Layered Peptide Arrays-high Throughput Screening
US Application 60/811,240
Filed on 2006-06-05

Prevention Of Tissue Ischemia

  • Read more about Prevention Of Tissue Ischemia
US Application 60/864,153
Filed on 2006-11-02

Novel Insertion Sites In Pox Vectors

  • Read more about Novel Insertion Sites In Pox Vectors
US Application 60/448,591
Filed on 2003-02-20

Macrocyclic Grb2 SH2 Domain-binding Inhibitors Prepared Using Achiral Alkenyl Amines

  • Read more about Macrocyclic Grb2 SH2 Domain-binding Inhibitors Prepared Using Achiral Alkenyl Amines
US Application 60/867,307
Filed on 2006-11-27

ENGINEERED ANTIBODY CONSTANT DOMAIN MOLECULES

  • Read more about ENGINEERED ANTIBODY CONSTANT DOMAIN MOLECULES
US Application 61/063,245
Filed on 2008-01-31

Identification Of A Dominant B Cell Epitope From NY-ESO-1: Implications For Antibody Detection Against Tumor-associated Antigens

  • Read more about Identification Of A Dominant B Cell Epitope From NY-ESO-1: Implications For Antibody Detection Against Tumor-associated Antigens
US Application 60/572,474
Filed on 2004-05-20

Peptide And Peptidomimetic Inhibitors Of Smoothened Protein As Anti-neoplastic Agents

  • Read more about Peptide And Peptidomimetic Inhibitors Of Smoothened Protein As Anti-neoplastic Agents
US Application 60/855,422
Filed on 2006-10-31

Aviden-Rhpdaminex (AV-3ROX) As A Self-Quenching Fluorophore Useful In Imaging Technology

  • Read more about Aviden-Rhpdaminex (AV-3ROX) As A Self-Quenching Fluorophore Useful In Imaging Technology
US Application 60/922,801
Filed on 2007-04-10

CKAP4/p63 Is A Bladder Epithelial Cell Bladder Cell Receptor For The Antiproliferative Factor (APF) From Interstitial Cystitis Patients

  • Read more about CKAP4/p63 Is A Bladder Epithelial Cell Bladder Cell Receptor For The Antiproliferative Factor (APF) From Interstitial Cystitis Patients
US Application 60/833,828
Filed on 2006-07-27

Methods And Compositions For Assessing Alterations In Gene Expression Patterns In Clinically Normal Tissues Obtained From Heterozygous Carriers Of Mutant Genes Associated With Cancer And Methods Of Use Thereof

  • Read more about Methods And Compositions For Assessing Alterations In Gene Expression Patterns In Clinically Normal Tissues Obtained From Heterozygous Carriers Of Mutant Genes Associated With Cancer And Methods Of Use Thereof
US Application 60/840,842
Filed on 2006-08-29

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 141
  • Page 142
  • Page 143
  • Page 144
  • Page 145
  • Page 146
  • Page 147
  • Page 148
  • Page 149
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health